MHRA says EU rules are unclear on software in medical devices

04/10/2013 | Clinica (subscription required)

The U.K. Medicines and Healthcare Products Regulatory Agency announced plans to work with the European Commission to clarify how proposed rules for medical devices and in vitro diagnostics affect software. The agency also plans to work with other EU stakeholders on defining "companion diagnostics" and "near patient-testing," and on supply chain responsibilities. Stakeholders told the agency that the proposed rules lack clarity, and many objected to proposed rules allowing some reprocessing of single-use devices.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN